These include mutations in p53 (up to 64% of tumours), p21 (up to 55%), p73 and MMAC1/PTEN tumour suppressor genes [15], as well as alterations in 25 PCa susceptibility loci [16], but these mutations do not explain all the observed effects on gene regulation. This evidence concerns the gene TP53 and neoplasm.